Pale Fire Capital Se Aquestive Therapeutics, Inc. Transaction History
Pale Fire Capital Se
- $842 Billion
- Q1 2025
A detailed history of Pale Fire Capital Se transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 1,335,684 shares of AQST stock, worth $3.93 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
1,335,684
Previous 525,756
154.05%
Holding current value
$3.93 Million
Previous $1.87 Billion
106.95%
% of portfolio
0.46%
Previous 0.42%
Shares
3 transactions
Others Institutions Holding AQST
# of Institutions
132Shares Held
41MCall Options Held
504KPut Options Held
148K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$28.8 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.45MShares$16 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.07MShares$12 Million0.0% of portfolio
-
Vr Adviser, LLC New York, NY2.63MShares$7.73 Million1.54% of portfolio
-
Geode Capital Management, LLC Boston, MA1.7MShares$5 Million0.0% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $157M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...